SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Stateside's Canadian Microcap Board -- Ignore unavailable to you. Want to Upgrade?

To: Dave@SI who wrote (1611)4/22/2016 9:14:25 AM
From: Dave@SI  Read Replies (1) | Respond to of 1728
 
BCT PP!
$650k from "Leading US Biotech Fund" (unnamed I think) 19c, full warrants (30c)
That's 3.4m * 2 shares according to my calc, so 4% dilution now and 4% fd.

Not too bad (but just a starter), I guess it may help that this investor gives some credibility.
And a bit less uncertainty.

"BriaCell intends to use the offering proceeds toward the Company's Phase I/IIa clinical trial, for advancing the BriaCell R&D program and companion diagnostic platform known as BriaDx™, and for general corporate purposes."



Also Nasdaq listing sought. Anyone remember the conditions?



To: Dave@SI who wrote (1611)4/22/2016 9:43:24 AM
From: PoorOpinion  Read Replies (1) | Respond to of 1728
 
Dave I had a quick look last night and it appears the HLA-A alleles are more common in asian populations, quite rare in usa Caucasian, I'll try to find some of the older publications describing the briavax cell line to see if there is an mention of the ethnicity. If I have time today I'll try to come up with a more complete answer.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News